In the BioHarmony Drug Report Database

"Preview" Icon

Captopril

Capoten (captopril) is a small molecule pharmaceutical. Captopril was first approved as Capoten on 1982-01-01. It is used to treat bartter syndrome, diabetic nephropathies, edema, heart failure, and left ventricular dysfunction amongst others in the USA. The pharmaceutical is active against angiotensin-converting enzyme. In addition, it is known to target angiotensin converting enzyme.

 

Trade Name

 

Capoten
 

Common Name

 

captopril
 

ChEMBL ID

 

CHEMBL1560
 

Indication

 

bartter syndrome, diabetic nephropathies, edema, heart failure, left ventricular dysfunction, malignant hypertension, raynaud disease, rheumatoid arthritis
 

Drug Class

 

Aptamers, classical and mirror; antihypertensives (ACE inhibitors)

Image (chem structure or protein)

Captopril structure rendering